Products
Zimbirelimab Biosimilar Monoclonal Antibody (PD-1) for Research
Cat No.: GMP-Bios-INN-1058
Anti-PDCD1/PD-1 therapeutic antibody (Pre-made Zimbirelimab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Order Information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-INN-1058-1mg | 1mg | 3090 |
| GMP-Bios-INN-1058-10mg | 10mg | |
| GMP-Bios-INN-1058-100mg | 100mg | |
| GMP-Bios-INN-1058-xmg | ≥100mg |
Product Details
| Products Name (INN Index) | Pre-Made Zimbirelimab Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
| INN Name | Zimbirelimab |
| Target | PDCD1/PD-1 |
| Format | Whole mAb |
| Derivation | human |
| Species Reactivity | human |
| CH1 Isotype | IgG4 - lambda |
| VD LC | IgG4 - lambda |
| Highest_Clin_Trial (Jan '20) | |
| Est. Status | |
| 100% SI Structure | |
| 99% SI Structure | |
| 95-98% SI Structure | |
| Year Proposed | |
| Year Recommended | |
| Companies | Arcus Biosciences, Inc. (Hayward CA USA) |
| Conditions Approved | |
| Conditions Active | |
| Conditions Discontinued | |
| Development Tech | OmniRat (Open Monoclonal Technology Inc (OMT)) |
